119 Views
Sunday Poster Session
Category: Colorectal Cancer Prevention
Akwe Nyabera, MD
Queens Hospital Center
Jamaica, NY, United States
Study | Study type | Ursodeoxycholic acid | Number of Patients | The primary outcome of colorectal cancer | |||
dose (mg/kg/day) | duration (year) | treatment group | placebo group | Ursodeoxycholic acid | Placebo group | ||
Navaneethan(29) | Cohort observational studies | 9 | >6 | 132 | 35 | 44 | 11 |
Pardi (30) | Randomized control trails | 13-15 | 3.5 | 29 | 23 | 3 | 8 |
Wolf (31) | Cohort observational studies | Not reported | 3.4 | 28 | 92 | 8 | 28 |
Tung (19) | Cohort observational studies | 8.9-9.9 | 3.5-4.2 | 41 | 18 | 13 | 13 |
Eaton (25) | Randomized control trails | 28-30 | 4 | 25 | 31 | 9 | 3 |
Braden (32) | Cohort observational trails | 15-20 | Not reported | 130 | 36 | 10 | 1 |
Lindstrom (33) | Randomized control trails | 17-23 | Not reported | 48 | 50 | 6 | 8 |